CL Hsu, KW Lui, LM Chi, YC Kuo,
YK Chao… - Journal of Experimental …, 2018 - Springer
Background Patient-derived xenograft (PDX) tumor model has become a new approach in
identifying druggable tumor mutations, screening and evaluating personalized cancer drugs …